APA

Yap T. A., Cortes-Funes H., Shaw H., Rodriguez R., Olmos D., Lal R., Fong P. C., Tan D. S., Harris D., Capdevila J., Coronado C., Alfaro V., Soto-Matos A., Fernández-Teruel C., Siguero M., Tabernero J. M., Paz-Ares L., de Bono J. S. & López-Martin J. A. (20120625). First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours. : British journal of cancer.

Chicago

Yap T A, Cortes-Funes H, Shaw H, Rodriguez R, Olmos D, Lal R, Fong P C, Tan D S, Harris D, Capdevila J, Coronado C, Alfaro V, Soto-Matos A, Fernández-Teruel C, Siguero M, Tabernero J M, Paz-Ares L, de Bono J S and López-Martin J A. 20120625. First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours. : British journal of cancer.

Harvard

Yap T. A., Cortes-Funes H., Shaw H., Rodriguez R., Olmos D., Lal R., Fong P. C., Tan D. S., Harris D., Capdevila J., Coronado C., Alfaro V., Soto-Matos A., Fernández-Teruel C., Siguero M., Tabernero J. M., Paz-Ares L., de Bono J. S. and López-Martin J. A. (20120625). First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours. : British journal of cancer.

MLA

Yap T A, Cortes-Funes H, Shaw H, Rodriguez R, Olmos D, Lal R, Fong P C, Tan D S, Harris D, Capdevila J, Coronado C, Alfaro V, Soto-Matos A, Fernández-Teruel C, Siguero M, Tabernero J M, Paz-Ares L, de Bono J S and López-Martin J A. First-in-man phase I trial of two schedules of the novel synthetic tetrahydroisoquinoline alkaloid PM00104 (Zalypsis) in patients with advanced solid tumours. : British journal of cancer. 20120625.